Tick Salivary Compounds for Targeted Immunomodulatory Therapy

Area of Science:

• Pharmacology
• Immunology
• Zoology

Background:

• Immunodeficiency and autoimmune diseases are prevalent, with limited effective treatments.
• Naturally derived compounds, particularly from tick saliva, show promise for novel drug development.
• Tick saliva contains diverse bioactive molecules that suppress host immune responses.

Purpose of the Study:

• To review the immunopharmacological potential of tick salivary compounds.
• To highlight non-coding RNAs in tick saliva as potential immunomodulatory therapies.
• To assess the current status and future directions for tick saliva-derived drug candidates.

Main Methods:

• Literature review of studies on tick salivary compounds.
• Analysis of *in vitro* and *in vivo* data on immunomodulatory effects.
• Examination of recent findings on non-coding RNAs in tick saliva.

Main Results:

• Tick saliva possesses a rich array of molecules, including proteins, peptides, and non-coding RNAs.
• These molecules exhibit significant immunomodulatory and immunosuppressive activities.
• Several tick salivary compounds show promise as therapeutic agents for immune-related diseases.

Conclusions:

• Tick saliva is a valuable source of novel immunomodulatory compounds.
• Non-coding RNAs represent an emerging class of therapeutic targets from tick saliva.
• Further molecular, cellular, and organismal validation is crucial for clinical translation.